@article{oai:rakuno.repo.nii.ac.jp:00002490,
 author = {YABUSAKI, Risa and 岩野, 英知 and TSUSHIMA, Sumito and KOIKE, Nanako and OHTANI, Naoko and TANEMURA, Kentaro and INOUE, Hiroki and YOKOTA, Hiroshi},
 issue = {11},
 journal = {The Journal of Veterinary Medical Science},
 month = {Nov},
 note = {Article, Bisphenol A (BPA) is a widely used industrial chemical that disrupts endocrine function. BPA is an endocrine disrupting chemical (EDC) that has been demonstrated to affect reproductive organ development, brain development, metabolic disease and post-natal behavior. Accordingly, Bisphenol analogs, Bisphenol F (BPF, bis (4-hydroxyphenyl) methane) and Bisphenol AF (BPAF, 4,4-hexafluoroisopropylidene) diphenol) are used as replacements for BPA. BPA is mainly metabolized by UDP-glucuronosyltransferase (UGT), UGT2B1, but this effective metabolizing system is weak in the fetus. In the present study, we demonstrated that hepatic UGT activity toward BPAF was very weak, in comparison with BPA and BPF, in the fetus, pups and dams. Conversely, hepatic UGT activity toward BPF was very weak in the fetus and newborn pups, and was increased to the same level as BPA post-partum. In conclusion, BPAF possibly tends to accumulate in the fetus, because of weak metabolism during the perinatal period, suggesting that the metabolism of individual Bisphenol analogs requires assessment to properly gauge their risks.},
 pages = {1479--1484},
 title = {Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development},
 volume = {77},
 year = {2015}
}